February 2, 2021 @ 7:11 pm | Breaking News, Jubak Picks Portfolio, Jubak Top 50 Portfolio, You May Have Missed |
As of 3:15 p.m. today, February 2, in New York, shares of GameStop (GME)were down 56.22% to $98.50. That a big drop from the January 27 closing high o #347.51, but it’s still significantly above th $17.25 price on January 4. Other stocks that have ridden the...
January 8, 2019 @ 7:50 pm | Breaking News, INCY, IONS, Jubak Picks Portfolio, NKTR, Update, Volatility |
Last week the biotech sector seemed in freewill. Bristol Myers Squibb (BMY) had made a deal to buy Celgene (CELG) at a whopping 54% premium to Wednesday’s close and the sector dropped on the news. The prevailing theory was that the deal removed one hungry big...
November 27, 2018 @ 7:30 pm | Breaking News, IONS, Jubak Picks Portfolio, Update |
It’s been a wild 2018 for Jubak Picks portfolio stock Ionis Pharmaceuticals (IONS.) Right now, though, the shares are on an upward trend. That’s likely to continue with the company looking at a strong research presentation at the December 1-4 meeting of...
November 18, 2016 @ 7:32 pm | IONS, Jubak Picks Portfolio, Update |
Sometimes the importance of a clinical trial extends way beyond the specific drug under study. That’s the case with the Phase II data recently released by Ionis for FIXRx. The trial did show efficacy in the treatment of kidney disease. But the most important...